Shares of Hinge Health rose 22.7% above the IPO price in their NYSE debut, giving the company a valuation of $3.65 billion. The valuation is lower than the $6.2 billion achieved in a 2021 funding round.
image sourced from original article at https://www.dailymail.co.uk/wires/reuters/article-14740429/Insight-Partners-backed-Hinge-Health-shares-jump-nearly-23-New-York-debut.htmlOriginal article source: https://www.dailymail.co.uk/wires/reuters/article-14740429/Insight-Partners-backed-Hinge-Health-shares-jump-nearly-23-New-York-debut.html
Source Id: 8690526956
